Silver nanoparticles as anti-microbial
    2.
    发明授权
    Silver nanoparticles as anti-microbial 有权
    银纳米颗粒作为抗菌剂

    公开(公告)号:US08314078B2

    公开(公告)日:2012-11-20

    申请号:US12796907

    申请日:2010-06-09

    IPC分类号: A61K31/70 C07H1/00 C07H5/04

    摘要: A silver nanocomposite, a formation method for forming the silver nanocomposite, and an application method utilizing the silver nanocomposite. The silver nanocomposite includes a silver nanoparticle conjugated to a glycosaminoglycan (GAG) or glucose. The formation method includes chemically reacting silver nitrate with a reducing agent to form a silver nanoparticle conjugated to the reducing agent of a GAG or glucose. The application method may include topically applying the silver nanocomposite to a wound or burn as an anti-microbial with respect to an antibiotic-resistant genotype in the wound or burn, wherein the silver nanocomposite topically applied includes the silver nanoparticle conjugated to the GAG of 2,6-diaminopyridinyl heparin (DAPHP) or hyaluronan (HA). The application method may include applying the silver nanocomposite as a coating to plastic, a catheter, or a surgical tool, wherein the silver nanocomposite applied as the coating includes the silver nanoparticle conjugated to the GAG of DAPHP.

    摘要翻译: 银纳米复合材料,形成银纳米复合材料的形成方法和利用银纳米复合材料的涂布方法。 银纳米复合材料包括与糖胺聚糖(GAG)或葡萄糖缀合的银纳米颗粒。 形成方法包括使硝酸银与还原剂化学反应以形成与GAG或葡萄糖的还原剂缀合的银纳米颗粒。 施用方法可以包括将伤口上的银纳米复合材料局部施用作为抗生素抗性基因型在伤口或烧伤中作为抗微生物剂,其中局部施用的银纳米复合材料包括与GAG缀合的银纳米颗粒2 ,6-二氨基吡啶基肝素(DAPHP)或透明质酸(HA)。 应用方法可以包括将银纳米复合物作为涂层施用于塑料,导管或外科工具,其中作为涂层施用的银纳米复合材料包括与DAPHP的GAG缀合的银纳米颗粒。

    HEPARAN SULFATE PROTEOGLYCAN COMPOSITION AND USE THEREOF
    5.
    发明申请
    HEPARAN SULFATE PROTEOGLYCAN COMPOSITION AND USE THEREOF 审中-公开
    HEPARAN硫酸酯蛋白质组合物及其用途

    公开(公告)号:US20100004196A1

    公开(公告)日:2010-01-07

    申请号:US12486272

    申请日:2009-06-17

    摘要: The present invention relates to method for the preparation of glycosaminoglycan compositions, isolated glycosaminoglycan compositions obtainable therefrom, glycosaminoglycan compositions, kits and use thereof. More specifically, the present invention provides a method for isolating glycosaminoglycan compositions of the invention from human follicular fluid. The compositions, related methods and uses according to the present invention are useful in the treatment and/or prevention of thrombotic diseases, cell proliferation disorders, proteolysis and inflammation mediated cell invasion and infertility.

    摘要翻译: 本发明涉及制备糖胺聚糖组合物的方法,由其获得的分离的糖胺聚糖组合物,糖胺聚糖组合物,试剂盒及其用途。 更具体地说,本发明提供了从人卵泡液中分离本发明的糖胺聚糖组合物的方法。 根据本发明的组合物,相关方法和用途可用于治疗和/或预防血栓形成疾病,细胞增殖障碍,蛋白水解和炎症介导的细胞侵袭和不育症。

    Method for synthesizing C-glycosides of ulosonic acids
    7.
    发明授权
    Method for synthesizing C-glycosides of ulosonic acids 失效
    尿苷酸的C-糖苷的合成方法

    公开(公告)号:US06376662B1

    公开(公告)日:2002-04-23

    申请号:US09142937

    申请日:1998-11-17

    IPC分类号: C07H704

    摘要: A method for synthesizing C-glycosides of ulosonic acids such as Neu5Ac, by which diastereocontrolled synthesis of &agr;-C-glycosides of ulosonic acids is attained is disclosed. In the method of the present invention, an ulosonic acid sulfone or phosphite is reacted with an aldehyde or ketone compound in the presence of a lanthanide metal halide.

    摘要翻译: 公开了用于合成诸如Neu5Ac的尿苷酸的C-糖苷的方法,通过该方法获得了关于酸性盐酸的α-C-糖苷的非对映控制合成。 在本发明的方法中,在镧系元素金属卤化物的存在下,将脲二
    酸砜或亚磷酸酯与醛或酮化合物反应。